Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
This report offers an overview of the market trends, drivers, and barriers with respect to the Japan Imatinib Drug market. It also provides a detailed overview of the market of different regions across Hokkaido, Tohoku, Kanto, Chubu, Kinki, Chugoku, Shikoku, Kyushu. The report deep analyzes type and application in Japan Imatinib Drug market. Detailed analysis of key players, along with key growth strategies adopted by Imatinib Drug industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.
By Player:
Novartis.
Dr. Reddy's Laboratories
Sanofi S.A.
Mylan Pharms Inc.
Sun Pharmaceuticals
Cipla Inc.
Glenmark Pharmaceuticals Ltd
Dr Reddy's Laboratories.
Apotex Inc
Actavis Generics.
By Type:
Tablets
Capsules
By End-User:
Chronic myelogenous leukemia
Gastrointestinal stromal tumors
Others
By Region:
-
Hokkaido
-
Tohoku
-
Kanto
-
Chubu
-
Kinki
-
Chugoku
-
Shikoku
-
Kyushu
1 Report Overview
-
1.1 Product Definition and Scope
-
1.2 PEST (Political, Economic, Social and Technological) Analysis of Imatinib Drug Market
-
1.3 Market Segment by Type
1.3.1 Japan Imatinib Drug Market Size and Growth Rate of Tablets from 2014 to 2026
1.3.2 Japan Imatinib Drug Market Size and Growth Rate of Capsules from 2014 to 2026
-
1.4 Market Segment by Application
1.4.1 Japan Imatinib Drug Market Size and Growth Rate of Chronic myelogenous leukemia from 2014 to 2026
1.4.2 Japan Imatinib Drug Market Size and Growth Rate of Gastrointestinal stromal tumors from 2014 to 2026
1.4.3 Japan Imatinib Drug Market Size and Growth Rate of Others from 2014 to 2026
-
1.5 Market Segment by Regions
-
1.5.1 Hokkaido Imatinib Drug Consumption Market Size and Growth Rate from 2014 to 2026
-
1.5.2 Tohoku Imatinib Drug Consumption Market Size and Growth Rate from 2014 to 2026
-
1.5.3 Kanto Imatinib Drug Consumption Market Size and Growth Rate from 2014 to 2026
-
1.5.4 Chubu Imatinib Drug Consumption Market Size and Growth Rate from 2014 to 2026
-
1.5.5 Kinki Imatinib Drug Consumption Market Size and Growth Rate from 2014 to 2026
-
1.5.6 Chugoku Imatinib Drug Consumption Market Size and Growth Rate from 2014 to 2026
-
1.5.7 Shikoku Imatinib Drug Consumption Market Size and Growth Rate from 2014 to 2026
-
1.5.8 Kyushu Imatinib Drug Consumption Market Size and Growth Rate from 2014 to 2026
2 Market Trends and Competitive Landscape
-
2.1 Market Trends and Dynamics
-
2.1.1 Market Challenges and Restraints
-
2.1.2 Market Opportunities and Potentials
-
2.1.3 Mergers and Acquisitions
-
2.2 Competitive Landscape Analysis
-
2.2.1 Industrial Concentration Analysis
-
2.2.2 Porter's Five Forces Analysis of the Industry
-
2.2.3 SWOT Analysis for New Entrants
3 Segmentation of Imatinib Drug Market by Types
-
3.1 Products Development Trends of Different Types
-
3.2 Commercial Products Types of Major Vendors
-
3.3 Competitive Landscape Analysis of Different Types
-
3.4 Market Size of Imatinib Drug by Major Types
3.4.1 Market Size and Growth Rate of Tablets
3.4.2 Market Size and Growth Rate of Capsules
4 Segmentation of Imatinib Drug Market by End-Users
-
4.1 Downstream Client Analysis by End-Users
-
4.2 Competitive Landscape Analysis of Different End-Users
-
4.3 Market Potential Analysis of Different End-Users
-
4.4 Market Size of Imatinib Drug by Major End-Users
4.4.1 Market Size and Growth Rate of Imatinib Drug in Chronic myelogenous leukemia
4.4.2 Market Size and Growth Rate of Imatinib Drug in Gastrointestinal stromal tumors
4.4.3 Market Size and Growth Rate of Imatinib Drug in Others
5 Market Analysis by Regions
-
5.1 Japan Imatinib Drug Production Analysis by Regions
-
5.2 Japan Imatinib Drug Consumption Analysis by Regions
6 Hokkaido Imatinib Drug Landscape Analysis
-
6.1 Hokkaido Imatinib Drug Landscape Analysis by Major Types
-
6.2 Hokkaido Imatinib Drug Landscape Analysis by Major End-Users
7 Tohoku Imatinib Drug Landscape Analysis
-
7.1 Tohoku Imatinib Drug Landscape Analysis by Major Types
-
7.2 Tohoku Imatinib Drug Landscape Analysis by Major End-Users
8 Kanto Imatinib Drug Landscape Analysis
-
8.1 Kanto Imatinib Drug Landscape Analysis by Major Types
-
8.2 Kanto Imatinib Drug Landscape Analysis by Major End-Users
9 Chubu Imatinib Drug Landscape Analysis
-
9.1 Chubu Imatinib Drug Landscape Analysis by Major Types
-
9.2 Chubu Imatinib Drug Landscape Analysis by Major End-Users
10 Kinki Imatinib Drug Landscape Analysis
-
10.1 Kinki Imatinib Drug Landscape Analysis by Major Types
-
10.2 Kinki Imatinib Drug Landscape Analysis by Major End-Users
11 Chugoku Imatinib Drug Landscape Analysis
-
11.1 Chugoku Imatinib Drug Landscape Analysis by Major Types
-
11.2 Chugoku Imatinib Drug Landscape Analysis by Major End-Users
12 Shikoku Imatinib Drug Landscape Analysis
-
12.1 Shikoku Imatinib Drug Landscape Analysis by Major Types
-
12.2 Shikoku Imatinib Drug Landscape Analysis by Major End-Users
13 Kyushu Imatinib Drug Landscape Analysis
-
13.1 Kyushu Imatinib Drug Landscape Analysis by Major Types
-
13.2 Kyushu Imatinib Drug Landscape Analysis by Major End-Users
14 Major Players Profiles
14.1 Novartis.
14.1.1 Novartis. Company Profile and Recent Development
14.1.2 Market Performance
14.1.3 Product and Service Introduction
14.2 Dr. Reddy's Laboratories
14.2.1 Dr. Reddy's Laboratories Company Profile and Recent Development
14.2.2 Market Performance
14.2.3 Product and Service Introduction
14.3 Sanofi S.A.
14.3.1 Sanofi S.A. Company Profile and Recent Development
14.3.2 Market Performance
14.3.3 Product and Service Introduction
14.4 Mylan Pharms Inc.
14.4.1 Mylan Pharms Inc. Company Profile and Recent Development
14.4.2 Market Performance
14.4.3 Product and Service Introduction
14.5 Sun Pharmaceuticals
14.5.1 Sun Pharmaceuticals Company Profile and Recent Development
14.5.2 Market Performance
14.5.3 Product and Service Introduction
14.6 Cipla Inc.
14.6.1 Cipla Inc. Company Profile and Recent Development
14.6.2 Market Performance
14.6.3 Product and Service Introduction
14.7 Glenmark Pharmaceuticals Ltd
14.7.1 Glenmark Pharmaceuticals Ltd Company Profile and Recent Development
14.7.2 Market Performance
14.7.3 Product and Service Introduction
14.8 Dr Reddy's Laboratories.
14.8.1 Dr Reddy's Laboratories. Company Profile and Recent Development
14.8.2 Market Performance
14.8.3 Product and Service Introduction
14.9 Apotex Inc
14.9.1 Apotex Inc Company Profile and Recent Development
14.9.2 Market Performance
14.9.3 Product and Service Introduction
14.10 Actavis Generics.
14.10.1 Actavis Generics. Company Profile and Recent Development
14.10.2 Market Performance
14.10.3 Product and Service Introduction
The List of Tables and Figures (Totals 80 Figures and 140 Tables)
Figure Japan Imatinib Drug Market Size and Growth Rate of Tablets from 2014 to 2026
Figure Japan Imatinib Drug Market Size and Growth Rate of Capsules from 2014 to 2026
-
Figure Market Share by Type in 2014
-
Figure Market Share by Type in 2018
-
Figure Market Share by Type in 2026
Figure Japan Imatinib Drug Market Size and Growth Rate of Chronic myelogenous leukemia from 2014 to 2026
Figure Japan Imatinib Drug Market Size and Growth Rate of Gastrointestinal stromal tumors from 2014 to 2026
Figure Japan Imatinib Drug Market Size and Growth Rate of Others from 2014 to 2026
-
Figure Market Share by End-User in 2014
-
Figure Market Share by End-User in 2018
-
Figure Market Share by End-User in 2026
-
Figure Hokkaido Imatinib Drug Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Tohoku Imatinib Drug Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Kanto Imatinib Drug Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Chubu Imatinib Drug Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Kinki Imatinib Drug Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Chugoku Imatinib Drug Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Shikoku Imatinib Drug Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Kyushu Imatinib Drug Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Development Trends and Industry Dynamics of Imatinib Drug Industry
-
Figure Market Challenges and Restraints
-
Figure Market Opportunities and Potentials
-
Table Mergers and Acquisition
-
Figure Market Share of TOP 3 Players in 2018
-
Figure Market Share of TOP 5 Players in 2018
-
Figure Market Share of TOP 6 Players from 2014 to 2019
-
Figure Porter's Five Forces Analysis
-
Figure New Entrant SWOT Analysis
-
Table Specifications of Different Types of Imatinib Drug
-
Figure Development Trends of Different Types
-
Table Commercial Products Types of Major Vendors
-
Figure Competitive Landscape Analysis of Different Types
-
Table Consumption of Imatinib Drug by Different Types from 2014 to 2026
-
Table Consumption Share of Imatinib Drug by Different Types from 2014 to 2026
Figure Market Size and Growth Rate of Tablets
Figure Market Size and Growth Rate of Capsules
-
Table Downstream Client Analysis by End-Users
-
Figure Competitive Landscape Analysis of Different End-Users
-
Table Market Potential Analysis of Different End-Users
-
Table Consumption of Imatinib Drug by Different End-Users from 2014 to 2026
-
Table Consumption Share of Imatinib Drug by Different End-Users from 2014 to 2026
Figure Japan Imatinib Drug Market Size and Growth Rate of Chronic myelogenous leukemia from 2014 to 2026
Figure Japan Imatinib Drug Market Size and Growth Rate of Gastrointestinal stromal tumors from 2014 to 2026
Figure Japan Imatinib Drug Market Size and Growth Rate of Others from 2014 to 2026
-
Table Japan Imatinib Drug Production by Regions
-
Table Japan Imatinib Drug Production Share by Regions
-
Figure Japan Imatinib Drug Production Share by Regions in 2014
-
Figure Japan Imatinib Drug Production Share by Regions in 2018
-
Figure Japan Imatinib Drug Production Share by Regions in 2026
-
Table Japan Imatinib Drug Consumption by Regions
-
Table Japan Imatinib Drug Consumption Share by Regions
-
Figure Japan Imatinib Drug Consumption Share by Regions in 2014
-
Figure Japan Imatinib Drug Consumption Share by Regions in 2018
-
Figure Japan Imatinib Drug Consumption Share by Regions in 2026
-
Table Hokkaido Imatinib Drug Consumption by Types from 2014 to 2026
-
Table Hokkaido Imatinib Drug Consumption Share by Types from 2014 to 2026
-
Figure Hokkaido Imatinib Drug Consumption Share by Types in 2014
-
Figure Hokkaido Imatinib Drug Consumption Share by Types in 2018
-
Figure Hokkaido Imatinib Drug Consumption Share by Types in 2026
-
Table Hokkaido Imatinib Drug Consumption by End-Users from 2014 to 2026
-
Table Hokkaido Imatinib Drug Consumption Share by End-Users from 2014 to 2026
-
Figure Hokkaido Imatinib Drug Consumption Share by End-Users in 2014
-
Figure Hokkaido Imatinib Drug Consumption Share by End-Users in 2018
-
Figure Hokkaido Imatinib Drug Consumption Share by End-Users in 2026
-
Table Tohoku Imatinib Drug Consumption by Types from 2014 to 2026
-
Table Tohoku Imatinib Drug Consumption Share by Types from 2014 to 2026
-
Figure Tohoku Imatinib Drug Consumption Share by Types in 2014
-
Figure Tohoku Imatinib Drug Consumption Share by Types in 2018
-
Figure Tohoku Imatinib Drug Consumption Share by Types in 2026
-
Table Tohoku Imatinib Drug Consumption by End-Users from 2014 to 2026
-
Table Tohoku Imatinib Drug Consumption Share by End-Users from 2014 to 2026
-
Figure Tohoku Imatinib Drug Consumption Share by End-Users in 2014
-
Figure Tohoku Imatinib Drug Consumption Share by End-Users in 2018
-
Figure Tohoku Imatinib Drug Consumption Share by End-Users in 2026
-
Table Kanto Imatinib Drug Consumption by Types from 2014 to 2026
-
Table Kanto Imatinib Drug Consumption Share by Types from 2014 to 2026
-
Figure Kanto Imatinib Drug Consumption Share by Types in 2014
-
Figure Kanto Imatinib Drug Consumption Share by Types in 2018
-
Figure Kanto Imatinib Drug Consumption Share by Types in 2026
-
Table Kanto Imatinib Drug Consumption by End-Users from 2014 to 2026
-
Table Kanto Imatinib Drug Consumption Share by End-Users from 2014 to 2026
-
Figure Kanto Imatinib Drug Consumption Share by End-Users in 2014
-
Figure Kanto Imatinib Drug Consumption Share by End-Users in 2018
-
Figure Kanto Imatinib Drug Consumption Share by End-Users in 2026
-
Table Chubu Imatinib Drug Consumption by Types from 2014 to 2026
-
Table Chubu Imatinib Drug Consumption Share by Types from 2014 to 2026
-
Figure Chubu Imatinib Drug Consumption Share by Types in 2014
-
Figure Chubu Imatinib Drug Consumption Share by Types in 2018
-
Figure Chubu Imatinib Drug Consumption Share by Types in 2026
-
Table Chubu Imatinib Drug Consumption by End-Users from 2014 to 2026
-
Table Chubu Imatinib Drug Consumption Share by End-Users from 2014 to 2026
-
Figure Chubu Imatinib Drug Consumption Share by End-Users in 2014
-
Figure Chubu Imatinib Drug Consumption Share by End-Users in 2018
-
Figure Chubu Imatinib Drug Consumption Share by End-Users in 2026
-
Table Kinki Imatinib Drug Consumption by Types from 2014 to 2026
-
Table Kinki Imatinib Drug Consumption Share by Types from 2014 to 2026
-
Figure Kinki Imatinib Drug Consumption Share by Types in 2014
-
Figure Kinki Imatinib Drug Consumption Share by Types in 2018
-
Figure Kinki Imatinib Drug Consumption Share by Types in 2026
-
Table Kinki Imatinib Drug Consumption by End-Users from 2014 to 2026
-
Table Kinki Imatinib Drug Consumption Share by End-Users from 2014 to 2026
-
Figure Kinki Imatinib Drug Consumption Share by End-Users in 2014
-
Figure Kinki Imatinib Drug Consumption Share by End-Users in 2018
-
Figure Kinki Imatinib Drug Consumption Share by End-Users in 2026
-
Table Chugoku Imatinib Drug Consumption by Types from 2014 to 2026
-
Table Chugoku Imatinib Drug Consumption Share by Types from 2014 to 2026
-
Figure Chugoku Imatinib Drug Consumption Share by Types in 2014
-
Figure Chugoku Imatinib Drug Consumption Share by Types in 2018
-
Figure Chugoku Imatinib Drug Consumption Share by Types in 2026
-
Table Chugoku Imatinib Drug Consumption by End-Users from 2014 to 2026
-
Table Chugoku Imatinib Drug Consumption Share by End-Users from 2014 to 2026
-
Figure Chugoku Imatinib Drug Consumption Share by End-Users in 2014
-
Figure Chugoku Imatinib Drug Consumption Share by End-Users in 2018
-
Figure Chugoku Imatinib Drug Consumption Share by End-Users in 2026
-
Table Shikoku Imatinib Drug Consumption by Types from 2014 to 2026
-
Table Shikoku Imatinib Drug Consumption Share by Types from 2014 to 2026
-
Figure Shikoku Imatinib Drug Consumption Share by Types in 2014
-
Figure Shikoku Imatinib Drug Consumption Share by Types in 2018
-
Figure Shikoku Imatinib Drug Consumption Share by Types in 2026
-
Table Shikoku Imatinib Drug Consumption by End-Users from 2014 to 2026
-
Table Shikoku Imatinib Drug Consumption Share by End-Users from 2014 to 2026
-
Figure Shikoku Imatinib Drug Consumption Share by End-Users in 2014
-
Figure Shikoku Imatinib Drug Consumption Share by End-Users in 2018
-
Figure Shikoku Imatinib Drug Consumption Share by End-Users in 2026
-
Table Kyushu Imatinib Drug Consumption by Types from 2014 to 2026
-
Table Kyushu Imatinib Drug Consumption Share by Types from 2014 to 2026
-
Figure Kyushu Imatinib Drug Consumption Share by Types in 2014
-
Figure Kyushu Imatinib Drug Consumption Share by Types in 2018
-
Figure Kyushu Imatinib Drug Consumption Share by Types in 2026
-
Table Kyushu Imatinib Drug Consumption by End-Users from 2014 to 2026
-
Table Kyushu Imatinib Drug Consumption Share by End-Users from 2014 to 2026
-
Figure Kyushu Imatinib Drug Consumption Share by End-Users in 2014
-
Figure Kyushu Imatinib Drug Consumption Share by End-Users in 2018
-
Figure Kyushu Imatinib Drug Consumption Share by End-Users in 2026
Table Company Profile and Development Status of Novartis.
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Novartis.
Figure Sales and Growth Rate Analysis of Novartis.
Figure Revenue and Market Share Analysis of Novartis.
Table Product and Service Introduction of Novartis.
Table Company Profile and Development Status of Dr. Reddy's Laboratories
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Dr. Reddy's Laboratories
Figure Sales and Growth Rate Analysis of Dr. Reddy's Laboratories
Figure Revenue and Market Share Analysis of Dr. Reddy's Laboratories
Table Product and Service Introduction of Dr. Reddy's Laboratories
Table Company Profile and Development Status of Sanofi S.A.
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Sanofi S.A.
Figure Sales and Growth Rate Analysis of Sanofi S.A.
Figure Revenue and Market Share Analysis of Sanofi S.A.
Table Product and Service Introduction of Sanofi S.A.
Table Company Profile and Development Status of Mylan Pharms Inc.
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Mylan Pharms Inc.
Figure Sales and Growth Rate Analysis of Mylan Pharms Inc.
Figure Revenue and Market Share Analysis of Mylan Pharms Inc.
Table Product and Service Introduction of Mylan Pharms Inc.
Table Company Profile and Development Status of Sun Pharmaceuticals
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Sun Pharmaceuticals
Figure Sales and Growth Rate Analysis of Sun Pharmaceuticals
Figure Revenue and Market Share Analysis of Sun Pharmaceuticals
Table Product and Service Introduction of Sun Pharmaceuticals
Table Company Profile and Development Status of Cipla Inc.
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Cipla Inc.
Figure Sales and Growth Rate Analysis of Cipla Inc.
Figure Revenue and Market Share Analysis of Cipla Inc.
Table Product and Service Introduction of Cipla Inc.
Table Company Profile and Development Status of Glenmark Pharmaceuticals Ltd
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Glenmark Pharmaceuticals Ltd
Figure Sales and Growth Rate Analysis of Glenmark Pharmaceuticals Ltd
Figure Revenue and Market Share Analysis of Glenmark Pharmaceuticals Ltd
Table Product and Service Introduction of Glenmark Pharmaceuticals Ltd
Table Company Profile and Development Status of Dr Reddy's Laboratories.
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Dr Reddy's Laboratories.
Figure Sales and Growth Rate Analysis of Dr Reddy's Laboratories.
Figure Revenue and Market Share Analysis of Dr Reddy's Laboratories.
Table Product and Service Introduction of Dr Reddy's Laboratories.
Table Company Profile and Development Status of Apotex Inc
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Apotex Inc
Figure Sales and Growth Rate Analysis of Apotex Inc
Figure Revenue and Market Share Analysis of Apotex Inc
Table Product and Service Introduction of Apotex Inc
Table Company Profile and Development Status of Actavis Generics.
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Actavis Generics.
Figure Sales and Growth Rate Analysis of Actavis Generics.
Figure Revenue and Market Share Analysis of Actavis Generics.
Table Product and Service Introduction of Actavis Generics.
-
